Clemens Scherzer, MD, is a physician-scientist and Adams Professor, founding director and section chief of the Stephen and Denise Adams Center for Parkinson’s Disease Research, an inter-departmental incubator of precision neurology at Yale School of Medicine. His goal is to predict and prevent the progression of Parkinson’s disease (PD). His laboratory aims to decipher how the human genome encodes billions of highly specialized brain cells and how glitches in this program drive disease. Dr. Scherzer launched the Harvard Biomarkers Study, a discovery platform for personalized medicine, and has pioneered the discovery of genetic drivers, biomarkers and therapeutic targets that are inspiring clinical trials. Dr. Scherzer serves on the scientific advisory board of the American Parkinson Disease Foundation and he has received the Dr. Paul Beeson and the George C. Cotzias Memorial Awards. His work was featured in Science, Scientific American, Washington Post, US News & World Report and NOVA Next.